“…The primary outcome, assessed from the initial MRI until death, emigration, or March 2015, was a new diagnosis of parkinsonism based on a validated definition (sensitivity, 81.7%; specificity, 99.7%; positive predictive value, 78.0%; negative predictive value, 99.8%; accuracy, 99.5%; and disease prevalence, 1.4%) using diagnosis codes from hospital admissions and physician visits or a dispensed Parkinson disease-specific medication. 4 We measured 105 covariates 5 and evaluated significant inequalities between patients who underwent only non-gadolinium-enhanced MRIs and those who underwent 1 or more gadoliniumenhanced MRI. A subset of 38 covariates particularly relevant to parkinsonism (based on potential associations from the literature) or significantly different at baseline (standardized difference >10%) were included in a multivariable timedependent extended Cox regression model using SAS (SAS Institute), version 9.4; the hazard ratio (HR) is interpreted as the hazard of parkinsonism per additional gadolinium exposure.…”